Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment

Jong Chan Youn; Darae Kim; Jae Yeong Cho; Dong Hyuk Cho; Sang Min Park; Mi Hyang Jung; Junho Hyun; Hyun Jai Cho; Seong Mi Park; Jin Oh Choi; Wook Jin Chung; Byung Su Yoo; Seok Min Kang

doi:10.36628/ijhf.2023.0011

Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment

Jong Chan Youn, Darae Kim, Jae Yeong Cho, Dong Hyuk Cho, Sang Min Park, Mi Hyang Jung, Junho Hyun, Hyun Jai Cho, Seong Mi Park, Jin Oh Choi, Wook Jin Chung, Byung Su Yoo, Seok Min Kang

Division of Cardiology

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evi-dence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction have since emerged. The current version has been updated based on international guidelines and research data on Korean patients with HF. Herein, we present Part II of these guidelines, which comprises treatment strategies to improve the outcomes of patients with HF.

Original language	English
Pages (from-to)	66-81
Number of pages	16
Journal	International Journal of Heart Failure
Volume	5
Issue number	2
DOIs	https://doi.org/10.36628/ijhf.2023.0011
State	Published - Apr 2023

Bibliographical note

Publisher Copyright:
© 2023. Korean Society of Heart Failure.

Keywords

Guideline
Heart failure
Pharmacotherapy
Treatment

Access to Document

10.36628/ijhf.2023.0011

Cite this

@article{589b13ae2f324da28cc6de54987a4a31,

title = "Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment",

abstract = "The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evi-dence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction have since emerged. The current version has been updated based on international guidelines and research data on Korean patients with HF. Herein, we present Part II of these guidelines, which comprises treatment strategies to improve the outcomes of patients with HF.",

keywords = "Guideline, Heart failure, Pharmacotherapy, Treatment",

author = "Youn, {Jong Chan} and Darae Kim and Cho, {Jae Yeong} and Cho, {Dong Hyuk} and Park, {Sang Min} and Jung, {Mi Hyang} and Junho Hyun and Cho, {Hyun Jai} and Park, {Seong Mi} and Choi, {Jin Oh} and Chung, {Wook Jin} and Yoo, {Byung Su} and Kang, {Seok Min}",

note = "Publisher Copyright: {\textcopyright} 2023. Korean Society of Heart Failure.",

year = "2023",

month = apr,

doi = "10.36628/ijhf.2023.0011",

language = "English",

volume = "5",

pages = "66--81",

journal = "International Journal of Heart Failure",

issn = "2636-154X",

publisher = "Korean Society of Heart Failure",

number = "2",

}

TY - JOUR

T1 - Korean Society of Heart Failure Guidelines for the Management of Heart Failure

T2 - Treatment

AU - Youn, Jong Chan

AU - Kim, Darae

AU - Cho, Jae Yeong

AU - Cho, Dong Hyuk

AU - Park, Sang Min

AU - Jung, Mi Hyang

AU - Hyun, Junho

AU - Cho, Hyun Jai

AU - Park, Seong Mi

AU - Choi, Jin Oh

AU - Chung, Wook Jin

AU - Yoo, Byung Su

AU - Kang, Seok Min

PY - 2023/4

Y1 - 2023/4

N2 - The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evi-dence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction have since emerged. The current version has been updated based on international guidelines and research data on Korean patients with HF. Herein, we present Part II of these guidelines, which comprises treatment strategies to improve the outcomes of patients with HF.

AB - The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evi-dence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction have since emerged. The current version has been updated based on international guidelines and research data on Korean patients with HF. Herein, we present Part II of these guidelines, which comprises treatment strategies to improve the outcomes of patients with HF.

KW - Guideline

KW - Heart failure

KW - Pharmacotherapy

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85168013717&partnerID=8YFLogxK

U2 - 10.36628/ijhf.2023.0011

DO - 10.36628/ijhf.2023.0011

M3 - Review article

AN - SCOPUS:85168013717

SN - 2636-154X

VL - 5

SP - 66

EP - 81

JO - International Journal of Heart Failure

JF - International Journal of Heart Failure

IS - 2

ER -

Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this